Erlonat Tablet (Erlotinib)
Erlotinib is used to treat metastatic-small cell lung cancer, as first-line treatment, maintenance treatment, or after the failure of one previous chemotherapy. Tarceva is another trade name for Erlotinib.
What is Erlotinib Tablet (Erlonat)?
Erlotinib, commonly known by its brand name Tarceva, is a medication used in the treatment of certain types of cancer. It falls under the category of targeted therapy, specifically classified as an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. Erlotinib is primarily used for the management of non-small cell lung cancer (NSCLC) and pancreatic cancer. There are different brands available for Erlotinib tablets. Each brand may have its own unique packaging and formulation, but they all contain the active ingredient Erlotinib. It is important to consult with a healthcare professional or pharmacist to determine the specific brand that suits your needs.
Dosage Information
The dosage of Erlotinib (Erlonat) varies depending on the specific condition being treated and the patient's individual factors. It is crucial to follow the prescribed dosage instructions provided by the healthcare professional. Erlotinib tablets are usually taken orally, typically on an empty stomach at least one hour before or two hours after meals. Swallow the tablet whole with a glass of water, without crushing or chewing it. If any difficulties arise in swallowing the tablet, consult a healthcare professional for alternative options. The recommended starting dose for Erlotinib in the treatment of NSCLC is 150 mg once daily. For pancreatic cancer, the standard dosage is 100 mg once daily. However, dosage adjustments may be necessary based on individual response and tolerance. It is important to adhere to the prescribed schedule and not miss any doses. In case of a missed dose, take it as soon as remembered unless it is close to the next scheduled dose. Do not take double doses to compensate for a missed one.
Erlotinib tablet 100 mg price:
You can easily check the price of Erlotinib tablet 100 mg at our online pharmacy. We provide a convenient platform where you can access up-to-date pricing information for Erlotinib tablets, allowing you to make informed decisions about your purchase.
Erlotinib Chemotherapy
Erlotinib tablet 150 mg is often referred to as Erlotinib Tarceva due to its well-known brand name. It is crucial to note that Erlotinib is a targeted therapy and not classified as a traditional chemotherapy drug. While chemotherapy drugs are cytotoxic and affect both cancer and healthy cells, Erlotinib specifically targets cancer cells by inhibiting the EGFR protein.
Erlotinib Generic Name
Erlotinib is the generic name for the medication commonly known by its brand name Tarceva. Generic medications are bioequivalent to their brand-name counterparts, containing the same active ingredients and delivering similar therapeutic effects. Choosing between generic and brand-name Erlotinib may depend on factors such as availability, cost, and individual preference. It is recommended to consult with healthcare professionals to determine the most suitable option.
In conclusion, Erlotinib (Erlonat), a Life-Saving Drug, commonly marketed as Tarceva, is a targeted therapy used in the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. It is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that inhibits the growth and spread of cancer cells. The dosage of Erlotinib varies based on the specific condition being treated and should be taken orally as prescribed by healthcare professionals. Erlotinib is not a traditional chemotherapy drug and is often used in combination with other treatments. To obtain accurate pricing information for Erlotinib, it is recommended to consult a reputable pharmacy or healthcare provider. Whether choosing the generic or brand-name option, it is important to discuss the available choices with healthcare professionals to ensure the most appropriate treatment.
Some Of The Primary Precautionary Measures To Be Taken While Using Erlonat Tablet (Erlotinib)
- Allergies: Prior to starting Erlotinib treatment, it is important to inform your healthcare professional about any known allergies or hypersensitivity reactions to Erlotinib or any other medications. This will help determine whether Erlotinib is suitable for you and if any alternative treatments should be considered.
- Pregnancy and Breastfeeding: Erlotinib may cause harm to an unborn baby, so it is essential to discuss pregnancy plans with your healthcare provider before starting treatment. Additionally, Erlotinib can pass into breast milk and may harm a nursing baby. Therefore, breastfeeding is not recommended during Erlotinib treatment.
- Liver and Kidney Function: Erlotinib/Tarceva is primarily metabolized in the liver, and its elimination is dependent on kidney function. Therefore, individuals with pre-existing liver or kidney diseases may require dose adjustments or careful monitoring while taking Erlotinib. Regular liver and kidney function tests are typically conducted to ensure the drug's safe use.
- Interstitial Lung Disease (ILD): Erlotinib has been associated with the development of ILD, a potentially serious lung condition characterized by inflammation and scarring of lung tissue. Inform your healthcare professional immediately if you experience symptoms such as cough, shortness of breath, or fever during Erlotinib treatment.
- Eye Disorders: Erlotinib can cause changes in vision, including blurred vision or dry eyes. If you experience any visual disturbances, consult your healthcare provider for further evaluation.
Key Application Of Erlotinib (Erlonat)
- Erlotinib is an Anti Cancer drug, that has been proven effective in the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. In NSCLC cases, Erlotinib is primarily prescribed for patients with locally advanced or metastatic NSCLC whose tumors have specific EGFR mutations. It helps inhibit the growth of cancer cells and slows down the progression of the disease. Erlotinib is often used as a first-line treatment option, either as a single agent or in combination with other therapies.
- For pancreatic cancer, Erlotinib/Tarceva is typically used in combination with gemcitabine, another chemotherapy drug. This combination has shown improved outcomes compared to gemcitabine alone. Erlotinib works by blocking the activity of the EGFR protein, which is involved in the growth and spread of cancer cells.
- Erlotinib is not a cure for cancer, but it can help improve the quality of life and extend survival in certain cases. It is essential to discuss the potential benefits and risks of treatment with Erlotinib with a healthcare professional.
Important Secondary Effects Of Erlonat Tablet (Erlotinib)
Skin Rash: One of the most common side effects of Erlotinib is a skin rash, which can range from mild to severe. Notify your healthcare provider if you develop a rash, as they may provide guidance on managing it and, in some cases, adjust the Erlotinib dosage.
Diarrhea: Diarrhea is another common side effect of Erlotinib. It is important to stay well-hydrated and notify your healthcare professional if diarrhea persists or becomes severe, as they may prescribe medications to manage it.
Fatigue: Erlotinib/Tarceva can cause fatigue and weakness. It is advisable to get plenty of rest and conserve energy while undergoing treatment.
Gastrointestinal Effects: Erlotinib may cause nausea, vomiting, loss of appetite, and abdominal pain. Inform your healthcare professional if these symptoms persist or worsen.
Liver Toxicity: Erlotinib can potentially cause liver toxicity, leading to elevated liver enzymes and other liver function abnormalities. Regular monitoring of liver function is necessary during treatment.
Respiratory and Breathing Issues: In some cases, Erlotinib can cause cough, shortness of breath, or difficulty breathing. Notify your healthcare provider if you experience any respiratory symptoms.
Other Common Side Effects: Erlotinib may also cause headaches, infection, dry skin, hair changes, nail disorders, and musculoskeletal pain. Inform your healthcare provider if any of these side effects become bothersome or persistent.
Quries About Erlotinib (Erlonat) May Occur
Q: Can Erlotinib (Erlonat) Be Used As A Standalone Treatment For Cancer?
A: Erlotinib is primarily used in combination with other treatments, such as chemotherapy or targeted therapies. It is rarely used as a standalone treatment. The specific treatment plan is determined by your healthcare professional based on your individual condition and needs.
Q: How Long Does It Take For Erlotinib/Tarceva To Show Its Effectiveness?
A: The effectiveness of Erlotinib/Tarceva varies from person to person. Some individuals may experience positive results within a few weeks, while others may require several months of treatment before seeing improvement. Your healthcare professional will closely monitor your response to Erlotinib and make any necessary adjustments to the treatment plan.
Q: Can Erlotinib Be Used In Pediatric Patients?
A: Currently, Erlotinib is not approved for use in pediatric patients. Its safety and efficacy in children have not been extensively studied. Treatment options for pediatric cancer patients are typically determined based on different protocols and medications specifically designed for pediatric use.
Q: What Should I Do If I Miss A Dose Of Erlotinib?
A: If you accidentally miss a dose of Erlotinib, take it as soon as you remember, unless it is close to the time for your next scheduled dose. Do not double the dose to make up for the missed one. If you have any concerns or questions regarding missed doses, consult your healthcare professional for guidance.
Q: Can Erlotinib Cause Long-Term Side Effects?
A: Some individuals may experience long-term side effects while on Erlotinib treatment. These can vary and may include skin changes, hair changes, or nail disorders. Additionally, Erlotinib can affect liver function, requiring regular monitoring. It is important to communicate any persistent or bothersome side effects to your healthcare professional for proper evaluation and management.
Possible Drug Interconnections With Erlonat Tablet (Erlotinib)
CYP3A4 Inducers and Inhibitors: Erlotinib is metabolized by the enzyme CYP3A4. Concurrent use of CYP3A4 inducers (e.g., rifampicin, carbamazepine) may decrease Erlotinib levels, while CYP3A4 inhibitors (e.g., ketoconazole, erythromycin) may increase Erlotinib levels. Dosage adjustments may be necessary when using Erlotinib in combination with these medications.
Proton Pump Inhibitors (PPIs): PPIs, commonly used to treat acid-related conditions, may reduce the absorption of Erlotinib. It is advisable to separate the administration of PPIs and Erlotinib by a few hours, as directed by your healthcare professional.
Warfarin and Anticoagulants: Erlotinib/Tarceva may interact with warfarin and other anticoagulant medications, potentially increasing the risk of bleeding. Close monitoring of blood clotting parameters is recommended when these medications are used together.
Herbal Supplements and Over-the-Counter Medications: Inform your healthcare professional about any herbal supplements or over-the-counter medications you are taking, as they may interact with Erlotinib and affect its effectiveness or increase the risk of side effects.
| Manufacturer | : | Natco Pharma, India |
| Equivalent Brand | : | Tarceva |
| Generic Search | : | Erlotinib |
